131 related articles for article (PubMed ID: 26462054)
1. Ultrasmall dual-modality silica nanoparticle drug conjugates: Design, synthesis, and characterization.
Yoo B; Ma K; Zhang L; Burns A; Sequeira S; Mellinghoff I; Brennan C; Wiesner U; Bradbury MS
Bioorg Med Chem; 2015 Nov; 23(22):7119-30. PubMed ID: 26462054
[TBL] [Abstract][Full Text] [Related]
2. Molecular Engineering of Ultrasmall Silica Nanoparticle-Drug Conjugates as Lung Cancer Therapeutics.
Madajewski B; Chen F; Yoo B; Turker MZ; Ma K; Zhang L; Chen PM; Juthani R; Aragon-Sanabria V; Gonen M; Rudin CM; Wiesner U; Bradbury MS; Brennan C
Clin Cancer Res; 2020 Oct; 26(20):5424-5437. PubMed ID: 32723835
[TBL] [Abstract][Full Text] [Related]
3. Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model.
Juthani R; Madajewski B; Yoo B; Zhang L; Chen PM; Chen F; Turker MZ; Ma K; Overholtzer M; Longo VA; Carlin S; Aragon-Sanabria V; Huse J; Gonen M; Zanzonico P; Rudin CM; Wiesner U; Bradbury MS; Brennan CW
Clin Cancer Res; 2020 Jan; 26(1):147-158. PubMed ID: 31515460
[TBL] [Abstract][Full Text] [Related]
4. Ligand-conjugated mesoporous silica nanorattles based on enzyme targeted prodrug delivery system for effective lung cancer therapy.
Sundarraj S; Thangam R; Sujitha MV; Vimala K; Kannan S
Toxicol Appl Pharmacol; 2014 Mar; 275(3):232-43. PubMed ID: 24467950
[TBL] [Abstract][Full Text] [Related]
5. Discovery of boron-conjugated 4-anilinoquinazoline as a prolonged inhibitor of EGFR tyrosine kinase.
Ban HS; Usui T; Nabeyama W; Morita H; Fukuzawa K; Nakamura H
Org Biomol Chem; 2009 Nov; 7(21):4415-27. PubMed ID: 19830290
[TBL] [Abstract][Full Text] [Related]
6. A Genomic Profile of Local Immunity in the Melanoma Microenvironment Following Treatment with α Particle-Emitting Ultrasmall Silica Nanoparticles.
Urbanska AM; Khanin R; Alidori S; Wong S; Mello BP; Almeida BA; Chen F; Ma K; Turker MZ; Korontsvit T; Scheinberg DA; Zanzonico PB; Wiesner U; Bradbury MS; Quinn TP; McDevitt MR
Cancer Biother Radiopharm; 2020 Aug; 35(6):459-473. PubMed ID: 32013538
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of oxygen-deficient luminescent mesoporous silica nanoparticles for synchronous drug delivery and imaging.
He Q; Shi J; Cui X; Wei C; Zhang L; Wu W; Bu W; Chen H; Wu H
Chem Commun (Camb); 2011 Jul; 47(28):7947-9. PubMed ID: 21499640
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and initial tumor affinity testing of iodine-123 labelled EGFR-affine agents as potential imaging probes for hormone-refractory prostate cancer.
Fozing T; Scheuer C; Samnick S
Eur J Med Chem; 2010 Sep; 45(9):3780-6. PubMed ID: 20538380
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors of the epidermal growth factor receptor.
Zhang X; Peng T; Ji X; Li J; Tong L; Li Z; Yang W; Xu Y; Li M; Ding J; Jiang H; Xie H; Liu H
Bioorg Med Chem; 2013 Dec; 21(24):7988-98. PubMed ID: 24183742
[TBL] [Abstract][Full Text] [Related]
10. Enzyme-responsive multifunctional magnetic nanoparticles for tumor intracellular drug delivery and imaging.
Yang Y; Aw J; Chen K; Liu F; Padmanabhan P; Hou Y; Cheng Z; Xing B
Chem Asian J; 2011 Jun; 6(6):1381-9. PubMed ID: 21548100
[TBL] [Abstract][Full Text] [Related]
11. Polyvalent nucleic acid/mesoporous silica nanoparticle conjugates: dual stimuli-responsive vehicles for intracellular drug delivery.
Chen C; Geng J; Pu F; Yang X; Ren J; Qu X
Angew Chem Int Ed Engl; 2011 Jan; 50(4):882-6. PubMed ID: 21246683
[No Abstract] [Full Text] [Related]
12. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J
Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of a novel magnetic drug delivery system composed of doxorubicin-conjugated Fe3O4 nanoparticle cores and a PEG-functionalized porous silica shell.
Chen FH; Zhang LM; Chen QT; Zhang Y; Zhang ZJ
Chem Commun (Camb); 2010 Dec; 46(45):8633-5. PubMed ID: 20941412
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional silica nanoparticles for targeted delivery of hydrophobic imaging and therapeutic agents.
Liu Y; Mi Y; Zhao J; Feng SS
Int J Pharm; 2011 Dec; 421(2):370-8. PubMed ID: 22001536
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of radioiodinated phenoxyquinazoline and benzylaminoquinazoline derivatives as new EGF receptor tyrosine kinase imaging ligands for tumor diagnosis using SPECT.
Hirata M; Kanai Y; Naka S; Matsumuro K; Kagawa S; Yoshimoto M; Ohmomo Y
Ann Nucl Med; 2012 Jun; 26(5):381-9. PubMed ID: 22354330
[TBL] [Abstract][Full Text] [Related]
16. Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade Glioma.
Aragon-Sanabria V; Aditya A; Zhang L; Chen F; Yoo B; Cao T; Madajewski B; Lee R; Turker MZ; Ma K; Monette S; Chen P; Wu J; Ruan S; Overholtzer M; Zanzonico P; Rudin CM; Brennan C; Wiesner U; Bradbury MS
Clin Cancer Res; 2022 Jul; 28(13):2938-2952. PubMed ID: 35499557
[TBL] [Abstract][Full Text] [Related]
17. γ-PGA-coated mesoporous silica nanoparticles with covalently attached prodrugs for enhanced cellular uptake and intracellular GSH-responsive release.
Du X; Xiong L; Dai S; Qiao SZ
Adv Healthc Mater; 2015 Apr; 4(5):771-81. PubMed ID: 25582379
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer.
Dominguez-Escrig JL; Kelly JD; Neal DE; King SM; Davies BR
Clin Cancer Res; 2004 Jul; 10(14):4874-84. PubMed ID: 15269164
[TBL] [Abstract][Full Text] [Related]
19. Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors.
van Rijt SH; Bölükbas DA; Argyo C; Datz S; Lindner M; Eickelberg O; Königshoff M; Bein T; Meiners S
ACS Nano; 2015 Mar; 9(3):2377-89. PubMed ID: 25703655
[TBL] [Abstract][Full Text] [Related]
20. Ultrasmall Folate Receptor Alpha Targeted Enzymatically Cleavable Silica Nanoparticle Drug Conjugates Augment Penetration and Therapeutic Efficacy in Models of Cancer.
Wu F; Chen PM; Gardinier TC; Turker MZ; Venkatesan AM; Patel V; Khor T; Bradbury MS; Wiesner UB; Adams GP; Germano G; Chen F; Ma K
ACS Nano; 2022 Dec; 16(12):20021-20033. PubMed ID: 36264003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
